IL13 and asthma: Therefore, several tailored biological treatments of asthma aim to lower BEC and thus ameliorate eosinophilic inflammation through targeting key inflammatory cytokines, e.g., interleukin (IL)-5, IL-4, and IL-13 (29,58).